FDA Inspection 642855 — Claris Lifesciences Inc

Claris Lifesciences Inc — FEI 3007003961

The FDA completed an inspection of Claris Lifesciences Inc on Feb 2, 2010 in North Brunswick, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 2, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Brunswick, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
682921 CFR 314.80(c)(2)Failure to report non-alert ADEs
683321 CFR 314.80(c)(2)(ii)(A)Incomplete periodic safety report
684121 CFR 314.80(f)(1)Incomplete patient information on ICSR

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.